Cetera Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,435
Closed -$242K 1739
2023
Q1
$242K Sell
1,435
-739
-34% -$132K ﹤0.01% 1399
2022
Q4
$368K Buy
2,174
+866
+66% +$157K 0.01% 1123
2022
Q3
$245K Buy
1,308
+34
+3% +$7.17K 0.01% 1053
2022
Q2
$207K Sell
1,274
-335
-21% -$53K ﹤0.01% 1226
2022
Q1
$303K Sell
1,609
-412
-20% -$78.3K 0.01% 1098
2021
Q4
$535K Sell
2,021
-100
-5% -$26.9K 0.01% 866
2021
Q3
$613K Buy
2,121
+57
+3% +$14.6K 0.01% 800
2021
Q2
$412K Sell
2,064
-14
-0.7% -$2.72K 0.01% 910
2021
Q1
$404K Sell
2,078
-198
-9% -$40.6K 0.01% 834
2020
Q4
$436K Buy
2,276
+100
+5% +$18.2K 0.01% 688
2020
Q3
$321K Hold
2,176
0.01% 708
2020
Q2
$269K Sell
2,176
-427
-16% -$50.2K 0.01% 733
2020
Q1
$251K Hold
2,603
0.01% 654
2019
Q4
$241K Hold
2,603
0.01% 796
2019
Q3
$200K Sell
2,603
-42
-2% -$3.67K 0.01% 830
2019
Q2
$228K Buy
+2,645
New +$180K 0.01% 810

Other funds holding RGEN

Cetera Advisors's RGEN Position: Q2 2023 in Review

Cetera Advisors sold out of Repligen (RGEN) in Q2 2023, closing a stake of 1,435 shares — an estimated $242K sold.

Cetera Advisors first reported a position in RGEN in Q2 2019 and held it in 16 quarters. The position peaked at $613K in Q3 2021. 446 funds tracked by Wall St. Rank hold RGEN as of Q2 2023.

  • Cetera Advisors reported no remaining Repligen position as of Q2 2023 after selling out during the quarter.
  • Cetera Advisors sold 1,435 Repligen shares in Q2 2023, an estimated $242K.
  • Cetera Advisors first reported a position in Repligen in Q2 2019 and held it in 16 quarters.
  • Cetera Advisors's Repligen position peaked at $613K in Q3 2021.
  • 446 funds tracked by Wall St. Rank held Repligen as of Q2 2023.

Based on Cetera Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.